Enzyme Contract Manufacturing - Market Insights, Competitive Landscape, and Market Forecast - 2030

The global Enzyme Contract Manufacturing market was valued at USD 2.24 billion in 2022 and is likely to register a CAGR of 8.31% during the forecast period from 2024 to 2030 to reach USD 3.62 billion by 2030. The demand for enzymes contract manufacturing is primarily being boosted owing to the growing pharmaceutical and healthcare sector, rising diagnostic and therapeutic value of enzymes, and increasing research and development. Also, the growing food and beverage industry, detergent industry, paper and textile industry, innovations along with new enzyme product launches are creating a positive market growth during the forecast period from 2024-2030.

Enzymes Contract Manufacturing Market Dynamics:

One of the key factors influencing the growth of the enzymes contract manufacturing market is the rising therapeutic value of enzymes. In recent years, enzymes from different origins including plant, animal, and microbes have risen as promising therapeutic tools for multiple pathologies which is expected to drive the market growth of enzyme contract manufacturing in coming years. The number of research publications have highlighted the therapeutic importance of range of enzymes including lipases, collagenases, and others which has led to the increased focus of pharmaceutical and biotech companies on developing enzyme based medications and therapies.

The numerous advantages including ability to bind and act on their targets with high affinity and specificity and ability to convert multiple target molecules into desired products among others associated with enzymes, make enzymatic treatment of diseases more effective in comparison to established therapeutic approaches. They are either used alone or in combination with other therapies for the effective and safe treatment of numerous diseases.

As the prevalence of these diseases including cardiovascular, cancer, HIV, skin diseases, and others is on rise, the therapeutic enzymes can play an essential role in their treatment and management.

For instance, as per the Global Cancer Observatory 2021 data, globally around 474,519 leukemia cases were reported in 2020. The enzyme L-glutaminase is a therapeutic agent for the treatment of patients with acute lymphoblastic leukemia (ALL). Enzymes such as Streptokinase and Urokinase act as thrombolytic agents and are crucial for the treatment of pulmonary embolism, acute myocardial infarction, and other cardiovascular diseases.

There are other enzymes that are used for treatment and management of genetic disorders. Some of the enzymes possess thrombolytic and anti-inflammatory properties.

Hence, due to growing importance of enzymes as therapeutic agents, the demand for them is likely to increase which is likely to propel the growth of overall enzyme contract manufacturing market during the forecast period from 2024-2030.

However, requirement of controlled environments of specific pH and temperature, along with the complexities during enzyme purification and isolation may restrict the growth of the enzymes contract manufacturing market.

Enzymes Contract Manufacturing Market Segment Analysis:

Enzymes Contract Manufacturing Market by Source (Plant, Animal, Microbe), Application (Industrial Enzymes [Food and Beverages, Animal Feed, Detergent, Paper and Others], Specialty Enzymes [Pharmaceutical Manufacturing, Diagnostic, Research and Development, and Others]) and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the source segment of the enzymes contract manufacturing market, the microbe category is expected to hold the largest share of 85.04% in the year 2023. This can be attributed to the wide applications and advantages associated with microbial enzymes in various industries for commercial purposes, leading to an increased market demand for enzymes contract manufacturing during the given forecast period.

Microbial enzymes are used in various sectors of food and beverage industry including dairy, baking, food processing and packaging, fruit and vegetable juice preparation, beverage production, and confectionery. a-Amylases obtained from different microorganisms have applications in baking, brewing, starch liquefaction, as well as in clarification of juices. The other microbial enzymes used in baking include xylanase, lipase, glucose oxidase, transglutaminase, and others where they are meant for dough strengthening, stability, conditioning, and other functions.

Enzymes such as phytase, xylanase, and ß-glucanase among others are the major microbial enzymes used in animal feed. These enzymes are known for improving the digestibility and metabolic energy values of animal feed which when consumed by animals enhances their overall performance, assist in weight gain, and improves the quality of litter by reducing the intestinal viscosity.

Thus, due to the applications of microbial enzymes in various industries, the interplay of all the above factors is expected to drive the growth of microbes category, thereby propelling the overall growth of the enzymes contract manufacturing market during the forecast period from 2023-2028.

North America is expected to dominate the overall Enzymes Contract Manufacturing Market:

Among all the regions, North America is expected to hold the largest share of 36.23% in the enzymes contract manufacturing market in 2022. Some of the factors responsible for the growth of North America’s enzymes contract manufacturing market are the increasing food and beverage industry, pharmaceutical industry, rising trend of contract manufacturing among others in the region will influence the growth of the microbe enzymes contract manufacturing.

Furthermore, the presence of key players, the rising research and development activities pertaining to enzymes is also driving the market growth of the enzymes contract manufacturing in North America.

Enzymes such as pectinases, amylases, and others are extensively used throughout the US for the processing of beverages to increase yield and improve processes such as extraction, clarification, and aroma enhancement compared to their chemical counterparts. In addition, the presence of various key players in the US such as Creative Enzymes, Enzymology Research Center, Inc., and other manufacturers will also aid in providing the best contract microbe enzyme manufacturing services, thereby increasing its demand in the region. For example, Creative Enzymes, a leading contract manufacturer of enzymes in the US, supplies quality microbial enzymes to be used in life sciences, research and production of medicines, food, alcohol, beer, fruit juice, fabric, paper, leather goods, etc.

Such key players within the country ensure that their in-house and worldwide client demands are met. The academic, commercial, and government laboratories in the country have been known to prefer enzymes through contract manufacturers for diverse applications, including basic research, drug discovery, cancer research, infectious disease research, microbiology, and personalized medicine.

Also, according to statistics by the Government of Canada (2023), drug research and development are being increasingly done via external partners such as contract research organizations (CROs), indicating that processes such as enzyme production are largely being carried out through contract manufacturers.

Therefore, the increase in the demand for enzymes contract manufacturing in the region will lead to a subsequent rise in the growth of the North America Enzymes Contract Manufacturing market during the forecast period from 2024-2030.

Enzymes Contract Manufacturing Market Key Players:

Some of the key market players operating in the Enzymes Contract Manufacturing market include EKF Diagnostics Holdings plc, Enzyme Bioscience, SEKISUI CHEMICAL CO., LTD., Creative Enzymes, Enzymology Research Center, Inc., Prozomix Limited, Tex Biosciences (P) Ltd, IBEX Technologies Inc., BRAIN Biotech AG, Meteoric Biopharmaceuticals Limited, Biovencer Healthcare Private Limited, Careprobio, Indus Gene, OENON Holdings, Inc., Ikeda Tohka Industries Co., Ltd, and others.

Recent Developmental Activities in the Enzymes Contract Manufacturing Market:

• In May 2021, BRAIN Biotech AG, acquired Biocatalysts Ltd., and has purchased an additional 16.7% in Biocatalysts Ltd. as two minority shareholders have exercised their put option rights. BRAIN now holds a total of 82.2% (previously 65.55%) in the daughter company. The purchase price was GBP 3.9 million.

Key Takeaways from the Enzymes Contract Manufacturing Market Report Study

• Market size analysis for current Enzymes Contract Manufacturing market size (2023), and market forecast for 6 years (2024-2030)
• The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Enzymes Contract Manufacturing market.
• Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
• Key companies dominating the global Enzymes Contract Manufacturing market.
• Various opportunities available for the other competitor in the Enzymes Contract Manufacturing market space.
• What are the top-performing segments in 2023? How these segments will perform in 2030?
• Which are the top-performing regions and countries in the current Enzymes Contract Manufacturing market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for Enzymes Contract Manufacturing Market growth in the coming future?

Target Audience who can be benefited from this Enzymes Contract Manufacturing Market Report Study

• Enzymes Contract Manufacturing products providers
• Research organizations and consulting companies
• Enzymes Contract Manufacturing-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and Traders dealing in Enzymes Contract Manufacturing
• Various End-users who want to know more about the Enzymes Contract Manufacturing market and the latest technological developments in the Enzymes Contract Manufacturing market.

Frequently Asked Questions for the Enzymes Contract Manufacturing Market:

1. What are Enzymes Contract Manufacturing?

Enzymes contract manufacturing is the production of enzymes, done by experts having extensive knowledge and experience in the development, optimization, and scaling up of enzyme production processes. Enzyme contract manufacturing involves the necessary infrastructure, equipment, and personnel to produce enzymes in large quantities at a lower cost than in-house production.

2. What is the market for global Enzymes Contract Manufacturing?

The global Enzyme Contract Manufacturing market was valued at USD 2.24 billion in 2022 and is likely to register a CAGR of 8.31% during the forecast period from 2024 to 2030 to reach USD 3.62 billion by 2030.

3. What are the drivers for the global Enzymes Contract Manufacturing market?

The demand for enzymes contract manufacturing is primarily being boosted owing to the growing pharmaceutical and healthcare sector, rising diagnostic and therapeutic value of enzymes, and increasing research and development. Also, the growing food and beverage industry, detergent industry, paper and textile industry, innovations along with new enzyme product launches are creating a positive market growth during the forecast period from 2024-2030.

4. Who are the key players operating in the global Enzymes Contract Manufacturing market?

Some of the key market players operating in the Enzymes Contract Manufacturing market include EKF Diagnostics Holdings plc, Enzyme Bioscience, SEKISUI CHEMICAL CO., LTD., Creative Enzymes, Enzymology Research Center, Inc., Prozomix Limited, Tex Biosciences (P) Ltd, IBEX Technologies Inc., BRAIN Biotech AG, Meteoric Biopharmaceuticals Limited, Biovencer Healthcare Private Limited, Careprobio, Indus Gene, OENON Holdings, Inc., Ikeda Tohka Industries Co., Ltd, and others.

5. Which region has the highest share in the Enzymes Contract Manufacturing market?

North America is expected to dominate the overall enzymes contract manufacturing market during the forecast period from 2024-2030. The factors responsible for the growth of North America’s enzymes contract manufacturing market are the increasing food and beverage industry, pharmaceutical industry, rising trend of contract manufacturing among others in the region. Furthermore, the presence of key players, the rising research and development activities pertaining to enzymes is also driving the market growth of the enzymes contract manufacturing in North America.


This product will be delivered within 2 business days.